Camille Turner
Adult Health · Smyrna, GANPI 1841619814
Payments from drug & device makers
Across 157 payments — averaging $28.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$640
- Astellas Pharma US Inc$591
- Axonics, Inc.$388
- Blue Earth Diagnostics$384
- Myriad Genetic Laboratories, Inc.$301
- Johnson & Johnson$248
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,18594%
- Education$2836%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 12 | $640 |
| Astellas Pharma US Inc | 19 | $591 |
| Axonics, Inc. | 10 | $388 |
| Blue Earth Diagnostics | 15 | $384 |
| Myriad Genetic Laboratories, Inc. | 13 | $301 |
| Johnson & Johnson | 9 | $248 |
| Myovant Sciences Inc. | 11 | $220 |
| Medtronic | 6 | $218 |
| Endo Pharmaceuticals Inc. | 10 | $205 |
| AstraZeneca | 5 | $201 |
| Angiodynamics, Inc. | 3 | $178 |
| AbbVie | 8 | $159 |
| Sumitomo Pharma America, Inc. | 6 | $146 |
| Verity Pharmaceuticals Inc. | 6 | $112 |
| Acerus Pharmaceuticals Corporation | 5 | $77 |
| Pfizer | 4 | $72 |
| Palette Life Sciences, Inc. | 2 | $46 |
| Endo USA, Inc. | 2 | $43 |
| 180 Medical, Inc. | 1 | $34 |
| Rochester Medical Corporation | 2 | $29 |
| Teleflex LLC | 1 | $28 |
| Tolmar, Inc. | 1 | $26 |
| ABC Home Medical Supply, Inc. | 1 | $24 |
| Accord Healthcare, Inc. | 1 | $23 |
| Procept Biorobotics Corporation | 1 | $22 |
| Medline Industries LP | 1 | $22 |
| Clarus Therapeutics Inc. | 1 | $17 |
| Progenics Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics r-SNM System$172
- GreenLight XPS$137
- AMS 700$134
- Nanoknife$116
- LYNPARZA$116
- Axonics$101
How this compares
$4,468 in reported general payments places this provider in the 85th percentile of 577 adult health providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 12 | $5,530 |
| Tamsulosin Hcl | 108 | $1,621 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $156 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $591 | $5,53012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 577 adult health providers in Georgia.
Other adult health in Smyrna
- Saeyoung LeeSmyrna$6K
- Patricia KeeganAtlanta$224K
- Diane WirthAtlanta$132K
- Barbara WeberAtlanta$74K
- Terry HackworthAtlanta$49K
- Jenny DicksonCumming$39K
- Rachel NejemLawrenceville$31K
- Melissa BaughcumAthens$23K
- Kristine AdamsMarietta$21K
- Jenina LagascaAtlanta$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.